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Abstract
Background The usual method for initial assessment of an
acute asthma attack in the emergency room includes the use
of peak flow measurement and clinical parameters. Both
methods have their own disadvantages such as poor
cooperation/effort from patients (peak flow meter) and lack
of objective assessment (clinical parameters). We were
looking into other methods for the initial asthma assessment,
namely the use of capnography. The normal capnogram has
an almost square wave pattern comprising phase 1, slope
phase 2,plateau phase 3,phase 4and angle α (betweenslopes
2 and 3). The changes in asthma include decrease in slope of
phase 2, increase in slope 3 and opening of angle α.
Aims Our objective was to compare and assess the
correlation between the changes in capnographic indices
and peak flow measurement in non-intubated acute asth-
matic patients attending the emergency room.
Methods We carried out a prospective study in a university
hospital emergency department (ED). One hundred and
twenty eight patients with acute asthma were monitored with
peak flow measurements and then had a nasal cannula
attached for microstream sampling of expired carbon
dioxide. The capnographic waveform was recorded onto a
PC card for indices analysis. The patients were treated
according to departmental protocols. After treatment, when
they were adjudged well for discharge, a second set of results
was obtained for peak flow measurements and capnographic
waveform recording. The pre-treatment and post-treatment
results were then compared with paired samples t-test
analysis. Simple and canonical correlations were performed
to determine correlations between the assessment methods.
A p value of below 0.05 was taken to be significant.
Results Peak flow measurements showed significant
improvements post-treatment (p<0.001). On the capno-
graphic waveform, there was a significant difference in the
slope of phase 3 (p<0.001) and alpha angle (p<0.001), but
not in phase 2 slope (p=0.35). Correlation studies done
between the assessment methods and indices readings did
not show strong correlations either between the measure-
ments or the magnitude of change pre-treatment and
post-treatment.
Conclusion Peak flow measurements and capnographic
waveform indices can indicate improvements in airway
diameter in acute asthmatics in the ED. Even though the two
assessment methods did not correlate statistically, capno-
graphic waveform analysis presents several advantages in
that it is effort independent and provides continuous
monitoring of normal tidal respiration. They can be proposed
for the monitoring of asthmatics in the ED.
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Introduction
Capnometry, discrete measurements of carbon dioxide
concentrations, was first developed during the Second
World War as a means of monitoring the internal
environment of submarines [1]. In the 1950s, capnometers
were used experimentally during anaesthesia to measure
expired CO2. But it was only in the early 1980s that
capnometry became widely used mainly in anaesthetic
practice [2]. Today, capnography is considered to be
essential in monitoring metabolic and respiratory functions
during anaesthesia. Its role has spread beyond the realms of
anaesthesia and capnography is now used in emergency
medicine to confirm and verify endotracheal tube place-
ment, monitor ventilatory status of patients with impaired
respiratory function, monitor ventilation of patients during
sedation/analgesia, evaluate ventilator settings and circuit
integrity, assess effectiveness of cardiopulmonary resusci-
tation, and for early detection of changes in airway
resistance and circulatory collapse. The normal capnogram
has an almost square wave pattern (Fig. 1), marked by
alternating inspiratory (PinspCO2 equals zero) and expiratory
phases [3, 4]. Expiration itself consists of three successive
phases: (1) a latency phase (phase 1), corresponding to the
expiration of the anatomical dead space (PexpCO2 equals
zero), which is indistinguishable from the preceding inspi-
ration; (2) slope phase (phase 2) marked by a very rapid rise
in PexpCO2, corresponding to expiration of mixed air; and (3)
plateau phase (phase 3), reflecting the elimination of alveolar
air (slightly increasing PexpCO2) resulting in a peak at the
end of tidal expiration (PetCO2 close to alveolar carbon
dioxide tensions PACO2)[ 5, 6]. The end-tidal peak is
occasionally referred to as the end-tidal point. This well-
defined shape of the normal capnograph depends on a
variety of factors. Normal aerobic metabolism will consume
oxygen and result in the production of carbon dioxide. This
will be carried by an adequately functioning circulatory
system to the lungs where, in the normal lung, matched gas
distributionandalveolarventilationwithpulmonaryperfusion
will ensure normal gas exchange. The elimination of alveolar
air is synchronous and this is reflected by the sudden rise of
phase 2 and the subsequent elimination of alveolar air, which
is indicated by the almost horizontal plateau of phase 3.
Asthma is a disease characterized by bronchial hyper-
reactivity, inflammatory exudates and mucous plugging.
The hallmark of asthma is the narrowing of the smaller
airways causing obstruction to flow within the airways
especially during expiration. In asthma, airway obstruction
causes regional decreases in airflow and consequently,
alveolar ventilation. This is responsible for the “parallel
heterogeneity” of ventilation-perfusion ratios (V/Q ratios).
On the capnogram, this causes deformation of the normal
curve, marked by the loss of verticality of phase 2, opening
of the angle between phases 2 and 3 (alpha angle also
known as angle Q) and the increased inclination of phase 3.
In severe cases, the capnogram takes on a “shark fin”
appearance (Fig. 2). These changes in the capnogram are of
particular interest as they indicate changes in airflow.
Asthmatics who present to the emergency department
(ED) with acute attacks of asthma are often required to
perform forced expiration manoeuvres to assess the degree
of airway obstruction and thereby the severity of the attack.
These manoeuvres are then repeated post-treatment to
confirm the return to baseline status. These manoeuvres
have been well studied and documented to accurately assess
severity of bronchospasm and they form the basis of almost
all monitoring of asthmatics in EDs throughout the world.
Nowak et al. in a series of landmark studies conducted in
the late 1970s and early 1980s reported on spirometric
criteria in patients with acute asthma in the ED [7]. These
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criteria for admission and discharge of patients from the
ED. The data from these studies formed the basis of many
of the recommendations concerning peak expiratory flow
rate (PEFR) values that are needed to discharge patients
from the ED that are in use today [8]. However, there are
several limitations to forced expiration manoeuvres. Most
significantly, they require an active and technically correct
effort to perform such manoeuvres [9]. Often, spirometric
measurements depend on whether medical staffs are able to
explain,motivateandguidepatientstoperformthemanoeuvres
properly and whether patients are willing and able to do them
[10]. Very often, this difficulty precludes the use of these
measurements in children, the elderly and the very dyspnoeic
patient. Capnography offers several advantages in this aspect;
it is non-invasive, non-effort related and independent of the
patient’s cooperation. It does not interfere with the adminis-
tration of oxygen nor does it delay onset of nebulizer therapy.
In fact, continuous monitoring of patients can be done during
their nebulizer therapy and throughout their stay in the ED. It
is this aspect of capnographic monitoring that greatly interests
many clinicians and researchers alike.
We conducted a study on patients who presented with
acute exacerbation of asthma to the emergency room in the
Hospital Universiti Sains Malaysia and carried out compar-
ison and correlation studies between the peak flow measure-
ment and the indices from the capnograph. The research was
approved by the University Hospital Ethics and Technical
Research Committee and was carried out as a partial
fulfilment for a Masters Degree in Emergency Medicine.
Methodology
We conducted a prospective study on patients presenting to
the ED with symptoms suggestive of asthma. This study
was conducted in the ED of Hospital Universiti Sains
Malaysia in Kubang Kerian,Kelantan. It isa regionaltertiary
referral centre with an attendance rate exceeding 60,000
patients per year for the ED. It is also a teaching institution
university hospital involved in the training of undergraduate
medical students and residency-based specialty training in
many fields including emergency medicine.
Inclusion criteria for enrolment into this study were all
adult patientswhopresentedwithsymptomsofbreathlessness
and/or wheezing and a self-reported previous history of
asthma. The Malaysian Constitution recognizes individuals
with age of 12 years and above as adults and the same rule
applies to the hospital admissions. The paediatric population
was excluded for one obvious reason, that is the difficulty to
obtain the PEFR reading. The diagnosis was further con-
firmed by looking into the patients’ old hospital notes. Any
patients with ambiguous diagnosis were excluded from the
study. These patients were initially examined clinically by
doctors working in the ED who assessed and documented
the severity of the attack via spirometric and clinical
parameters. The patients were managed according to
standard protocol for acute exacerbation of asthma as
recommended by the Malaysian Thoracic Society. These
patients were then started on nebulizer therapy and enrolled
inthestudy.Initialverbalconsentwastakenifpatientswere
in a state of breathlessness or written consent was taken
fromtherelativesiftheywerepresentduringtheemergency
room admission. Patients were excluded from the study if
they presented with severe life-threatening events where
priority and attention was directed towards treatment. They
were also excluded if chronic obstructive pulmonary
disease (COPD) was suspectedt ob et h ep r i m a r yd i a g n o s i s
due to the irreversibilityofatleastsomeairway obstruction,
as is well documented in this disease [11]. Inability to
perform forced expiration manoeuvres, either pre-treat-
ment or post-treatment, excluded any patient from enrol-
ment. Anticipating this difficulty, we had decided to
exclude children from the study. All patients whose
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therapy and/or required admission were also excluded.
Patients were instructed to blow forcefully into the
Wright’s® Mini Peak Flow Meter (PEFR) thrice and all
three measurements were recorded. For the purpose of
analysis, the highest reading constituted the PEFR reading
for the patient. The PEFR readings were represented as
percentage of expected based on the normogram for
prediction of PEFR based on age and height in men and
women. Once the decision to start nebulizer therapy was
given, the attending physician initiated capnographic mon-
itoring in tandem with ongoing therapy. In this study we
used a Novametrix Capnogard® capnograph, manufactured
in the USA, which needed daily calibration. A nasal cannula,
which served as the sampling port for sidestream capnog-
raphy, was applied to the patient. They were then directed to
breathe normally. One end of this specially designed nasal
cannula provided oxygen from a humidified wall source (all
patients in this study were given oxygen at a rate of 3 l/min
via this nasal cannula) whereas the other end was connected
to an aspiration pump and the sampling port [12, 13]. The
capnogram was then recorded and stored within a PC card.
Waveforms were deemed adequate once at least three
waveforms of regular morphology, without significant
artefacts, were noted. Nebulizer therapy was then started
with the nasal cannula in situ. All patients were treated with
oxygen-driven wet nebulizers. At the conclusion of nebulizer
therapy, once the attending doctor had decided that the
patient was “fit for discharge”, the post-treatment capno-
graphic waveforms and PEFR were again recorded and
stored [13]. Carbon dioxide readings were measured 48
times/s, i.e. at intervals of 0.02 s. The capnogram recorded
was stored in “comma-separated variable” (*.csv) data files
for analysis. The capnograph machine was calibrated daily
as recommended by the manufacturer.
Each capnograph was analysed for phase 2 slope
(referred to subsequently as “slope”) and phase 3 slope
(referred to as “plateau”). The slope and plateau lines would
create an obtuse angle with each other and this we referred
to as angle α. In all graphical analysis, the difficulty in
producing computerized analysis always lies in the identi-
fication of constants or specifics within each waveform that
allow for repeated and reproducible analysis. With this in
mind, we decided to study the slope of phase 2 as measured
for 0.25 s from the first point where the measured CO2 first
rose above 4 mmHg and the slope of phase 3 as measured
for 0.75–0.25 s (total time 0.5 s) from the end-tidal point.
All patients’ capnographs had three readings taken for slope
and plateau, and therefore three values of α were
calculated. Mean readings were then taken of the three
initial readings. Variables were reported as mean with
standard deviations. Statistical analysis was performed
using SPSS (Version 9.0) and Stata (Version 7.0). Among
the statistical tests used were frequency analysis, paired
t-tests for comparison of means, simple and canonical
correlations to determine correlations between tests and
Wilcoxon non-parametric signed rank test for analysis of
categorical data. While it must be recognized that blood
pressures, respiratory rates and pulse rates are widely
different from patient to patient and dependent on age,
sex, underlying disease and degree of anxiety besides
severity of disease, the paired t-test only compared changes
in each individual patient thereby negating any inter-
individual variability. A value of p<0.05 was considered
to be statistically significant.
Results
A total of 128 patients were initially enrolled in this study.
Eight patients were not included in the study due to
inability to analyse their capnographic records, primarily
due to lack of adequate waveforms not deformed by
artefacts. Sixteen patients were unable to perform the PEFR
measurement due to poor effort and to distress from
breathlessness and were hence excluded from the study. Four
other patients were excluded due to missing or incomplete
data. Data from 100 patients were submitted for analysis.
The age of our patients in this study ranged from 12 to
71 years with a mean of 35.2 years [95% confidence
interval (CI): 22.5–45.3]. There were 56 male and 44
female patients. The range for height was from 137 to
176 cm with a mean of 158.7 cm (95% CI: 45.3–172.8)
whereas their weights ranged from 35 to 100 kg with a
mean of 60.6 kg (SD±17.1 kg). Of the 100 patients, 30%
(n=30) received just nebulized Salbutamol as their treat-
ment in the ED; 53.3% (n=53) had nebulized Salbutamol
followed by Salbutamol with Ipratropium, and the remain-
ing 16.7% (n=17) had the above with I.V. bolus of
Hydrocortisone 200 mg. Of the patients, 87% (n=87) were
discharged from the emergency room with outpatient
follow-up and none of them returned with the same
complaint within the 24 h post-discharge; 13% (n=13) of
them required further 24-h observation in the emergency
room observation ward before being discharged home.
None of the patients were admitted to the general medical
ward (Table 1).
Initial PEFR readings were used to grade the severity of
the asthmatic attack. Of the 100 patients in the study, 63%
(n=63) had a PEFR<50% of expected on admission; 26%
(n=26) had an initial PEFR between 50 and 80% and 11%
(n=11) had a PEFR of more than 80% of expected. At the
conclusion of therapy, when all patients were fit for
discharge, 67 in total or 66.7% now had a PEFR of
between 50 and 80% and 33% (n=33) had a PEFR of more
than 80% of expected. Paired samples analysis showed a
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(p<0.001) (Fig. 3). End-tidal carbon dioxide (EtCO2) levels
were also recorded pre- and post-treatment. EtCO2 levels
pre-treatment ranged from 24 to 49 mmHg with a mean of
36.8 mmHg (95% CI: 32.4–41.7). This was essentially
unchanged post-treatment (range: 30–46 mmHg; mean:
36.7 mmHg; 95% CI: 31.2–38.4). The paired t-test did not
show any significant difference (p=0.871).
Gradient values for phase 2 had a mean of 2.61 (95%
CI: 2.11–2.93) pre-treatment and a mean of 2.74 (95%
CI: 2.54–2.95) post-treatment. The paired t-test showed this
to have no significant difference (p=0.35). Gradient values
for phase 3 had a mean of 0.44 (95% CI: 0.33–0.47) pre-
treatment and a mean of 0.23 (95% CI: 0.21–0.28) post-
treatment.Thisreduction was markedly significant(p<0.001).
The angle α was calculated from the observed gradients
of phases 2 and 3. The pre-treatment mean of 134.36 (95%
CI: 129.53–138.74) was significantly higher than the post-
treatment mean of 123.27 (95% CI: 121.25–127.96)
(p<0.001). Simple correlations were performed for numerical
data whereas canonical correlations were used to analyse
correlations between groups of variables. Correlation studies
were conducted to attempt to correlate PEFR readings
(analysed as percentage of expected) and graphical indices
(phases 2 and 3 slopes and angle α) in their ability to detect
changes pre-treatment and post-treatment.
There were poor correlations between pre-treatment
PEFR readings and graphical indices, i.e. between PEFR
a n dp h a s e2s l o p e( r=0.60, 95% CI: 0.55–0.68), and phase 3
slope (r=−0.43, 95% CI: −0.36 to −0.48) and α (r=−0.57,
95% CI: −0.48 to −0.61). Post-treatment, we also noted
weak correlations between PEFR readings and graphical
indices: phase 2 (r=0.21, 95% CI: 0.17–0.28), phase 3
(r=−0.39, 95% CI: −0.31 to −0.45) and α (r=−0.48, 95%
CI: −0.41 to −0.54). (Note: negative r values indicate
inverse/negative correlation). We also looked at the magni-
tude of change in PEFR and graphical indices pre- and post-
treatment. We then conducted correlation studies after
generating variables of differences. There was weak corre-
lation between the magnitude of change in PEFR and phase
2 pre- and post-treatment (r=0.48). Similarly, there were
only weak negative correlations between the magnitude of
change in PEFR and phase 3 (r=−0.24, 95% CI: −0.18 to
−0.31) and α (r=−0.31, 95% CI: −0.26 to −0.38) pre- and
post-treatments. In conclusion, there were poor correlations
between the magnitudes of change in PEFR and change in
graphical indices, pre-treatment and post-treatment.
Discussion
Many of the previous studies on capnography in asthmatics
have been conducted in more controlled situations, either
with asthmatic patients in histamine challenge tests or
whose asthma status has been stable for a few hours [14,
15]. On the contrary, this study was conducted on asthmatic
patients presenting to the ED with an acute attack of
asthma. We presume our findings are reflective of the
situation in the ED, given our study population.
This study stands on one central pillar, that is the
attending doctor according to departmental protocol (based
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Table 1 Patient characteristics
Characteristic
Median age, years (range) 35.2 (12–71)
Sex female:male (ratio) 1:1.5 (40:60)
Median weight, kg (range) 60.6 (35–100)
Height, cm (range) 158.7 (137–176)
Patients received nebulized beta2-agonist alone 30% (n=30)
Patients received nebulized beta2-agonist and ipratropium bromide 53% (n=53)
Patients received intravenous hydrocortisone 17% (n=17)
Patients received combination beta2-agonist and steroid inhaler on discharge 100% (n=100)
Patients discharged home after completing treatment in emergency room 87% (n=87)
Patients admitted to emergency room observation ward (maximum 24-h stay) 13% (n=13)
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patients in the study population without any influence from
the researcher [16]. The researcher who was blinded to the
clinical scenario analysed the data post hoc. Unfortunately
it was hard to blind the attending physicians and the
patients as the capnograph monitor was located next to the
patients’ beds. In other words, the ED doctor decided if
the patient had an asthmatic attack and whether treatment
was necessary. The end point of treatment, also decided by
this doctor, occured when the patient was adjudged well
and safe for discharge. We monitored these patients with
clinical parameters, peak flow readings and capnographic
waveform recordings. Capnographic waveform analysis is
relatively new and is, as yet, unproven in its ability to detect
changes in the airway of the asthmatic patient.
Currently, peak flow measurements are the most widely
used method of objectively monitoring patients with acute
asthma. Theoretically, peak flow rates are more a function
of the diameter of the larger airways while forced
expiratory volume in 1 s (FEV1) or FEV1/forced vital
capacity (FVC) reflect the smaller airways. FEV1 and
FEV1/FVC are technically difficult to perform in the ED
and involve cumbersome equipment. Many studies have
shown that PEFR can be reliably used not only as a
reflection of severity of the asthmatic attack, but also to
indicate when patients should be admitted or can be
discharged [17–19]. The major drawback is its dependency
on effort. The patient’s ability to perform these manoeuvres
is vital. Often, in the ED, we find patients unable to
perform these manoeuvres. Some are unmotivated to
perform any manoeuvre in the midst of their discomfort,
anxiety and breathlessness. Many, having performed such
tests before, claim a worsening of symptoms especially
cough after the manoeuvre. Some have such severe
bronchospasm that they are totally unable to generate any
significant flow at all. In the context of a study, all this
introduces bias and skewed results. This was reflected in
the study when 12% (n=16) of the patients were excluded
because they were too distressed to blow into the peak flow
meter. Practically speaking, the inability of the patients to
produce pre-treatment PEFR now renders any post-treatment
reading less useful; and any PEFR reading obtained may be
spuriously low as a result of poor performance. PEFR then
cannot be used alone to assess and monitor a patient in the
ED. These limitations of peak flow manoeuvres are well
known; but for the lack of a better monitoring technique, it is
still the most reliable, and so the most widely used technique
today.
The capnographic waveform shows changes in broncho-
spasm that reflect the heterogeneity of the expired air. This
is seen as a decrease in the slope of phase 2 and increase of
the slope of phase 3 and the resultant increase in the alpha
angle (angle α). While gross changes are visible to the
naked eye, e.g. “shark fin appearance”, more subtle changes
require measurement of the slopes and angles. In this study,
all the capnograms produced were trapezoid shaped which
is a very common shape for those who present with mild to
moderate asthma. The shark fin shaped capnogram would
be most likely found in patients presenting with a very
severe asthma attack who unfortunately were excluded
from the study due to inability to use the peak flow meter.
Since this is still a new concept, all studies to date have
done this manually [15, 16]. We have taken a slightly
different approach. Keeping in view that any future
application of this concept would require computerized
analysis of the capnographic waveform, we set out by using
indices that can be identified easily by computerized
algorithm. For the slope of phase 2, we obtained readings
for a period of 0.2 s from the point when the capnographic
waveform crosses the carbon dioxide reading of 4 mmHg,
assuming that the carbon dioxide has to have come from the
lungs to reach a level of 4 mmHg. The second point
identified was the end-tidal point, already a commonly
identified point in all capnometers used today. We
measured the slope of phase 3 by measuring for a period
of 0.5 s from a point 0.25 s from the end-tidal point. These
readings were then subjected to trend line analysis,
resulting in the slope. From the two slopes, the angle of
alpha (α) was calculated.
You et al., in their series of studies, have shown that
slopes of phases 2 and 3 change demonstrably with
improvements in airway diameter. They concluded that
indices based on the later parts of the capnographic
waveform are more sensitive and display a stronger
correlation with spirometric indices [5]. In our study, we
noted a similar trend, where phase 2 slopes did not show
any significant change pre-treatment and post-treatment
(p=0.35). Thisisincontrastwiththe significant changes seen
in phase 3 (p<0.001) and alpha angle (angle α)( p<0.001).
Althoughphase3slopeandalpha angle(angleα)changes
were significantly different pre- and post-treatment, the
correlations with peak flow meter measurements were poor.
In other terms, capnographic waveform indices were able to
detect improvements in the patients’ bronchospasm post-
treatment, as could peak flow measurements, but the
magnitude of improvement was poorly correlated between
the two monitoring techniques. The poor correlation be-
tween the two parameters could be attributed to the poor
initial PEFR effort by the patients because of the acute
breathlessness state, thus contributing to the poor magnitude
of changes in the PEFR reading. The question that needs to
be asked then is: which then is the better monitoring
parameter? There are insufficient studies at the moment to
conclude this to any degree of certainty. Therefore, whether
capnography is more accurate at detecting changes in asthma
can only be answered by further studies. We were also
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groups of patients who were discharged home and admitted
to the ward because all the patients included in the study
were discharged from the emergency room eventually.
There are certain weaknesses to this study that we must
acknowledge. Firstly, the study population was small.
Distributions with respect to age or sex were not noted;
however, there is no evidence to suggest that the shape of the
capnogram is dependent on age or sex. A source of bias would
be the selection of waveforms for analysis; waveforms were
recorded when the morphology looked “similar” to the
researcher and analysis was conducted on waveforms that were
n o te x c l u d e do rd e f o r m e db ya r t e f acts. This is a selection bias.
There are several possible approaches to this problem. Firstly,
strict exclusion criteria may be imposed to sieve out waveforms
with artefacts. This runs the risk of analysing waveforms that
may not be indicative of the situation or having too few
waveforms to analyse. Secondly, as Goldman and Landis have
proposed, recognition of the different waveform morphologies,
either through neural network algorithms or as clusters of
morphologically similar waveforms, can be programmed [20–
22]. On the whole, this will reduce the influence of waveforms
with artefacts or sub-optimal waveforms and this may then
form the basis of waveform selection for analysis.
At the present moment, research into capnography
waveform analysis is still evolving. Multiple avenues are
being explored. Though we are still unclear of the future
directions of this research, and how capnographic waveform
analysis will be conducted in the future, the potential for its
use practically demands further research into this field.
Conclusion
Even though the study did not show strong correlation
between the measurements of the capnographic indices and
peak flow meter, the former did show significant changes pre-
and post-treatment. More research is required in future to
prove whether capnography has a potential in future as a
methodformonitoringtheacuteasthmapatient,inparticularto
assist physiciansindeciding the effectiveness of thetreatment.
Conflicts of interest None.
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